Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522103 · ClinicalTrials.gov registry record
Cannabis Observational Study on Mood, Inflammation, and Cognition
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 421
- Enrollment target
NCT03522103 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 421 participants.
The verdict
NCT03522103 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 421 participants
- Enrollment target
Study Summary
This project examines the effects of cannabis on cognition and other domains of function and whether those effects are dependent upon the ratio of THC to CBD in the product. Current cannabis users are asked to stop using their typical product and to use cannabis containing different ratios of the cannabinoids THC and CBD. Participants complete baseline assessments including cognitive tasks, clinical measures, substance use history, and blood draw. Participants then acquire and use their study strain on their own, and after a period of use the mobile pharmacology laboratory goes to a location of their choosing. They complete cognitive, motor and blood-based assessments, then leave the mobile lab to use their study product one last time, returning to the mobile lab to complete cognitive, motor, and blood-based assessments immediately after use and one hour after use. A small subset of participants complete all of these procedures but use edible as opposed to flower-based products.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2020-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03522103
The ClinicalTrials.gov registry entry for NCT03522103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 421 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03522103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03522103 about?
NCT03522103 is a clinical study titled "Cannabis Observational Study on Mood, Inflammation, and Cognition". This project examines the effects of cannabis on cognition and other domains of function and whether those effects are dependent upon the ratio of THC to CBD in the product. Current cannabis users are asked to stop using their typical product and to use cannabis containing different ratios of the ca...
What is the current status of trial NCT03522103?
This trial is currently completed. The enrollment target is 421 participants. The study started on 2016-07-01. Estimated completion is 2020-12-15.
Who is sponsoring clinical trial NCT03522103?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.